Pharmaceutical

We offer a complete range of chromatography resins for the purification of mAbs, bispecific antibodies, and ADCs. This includes Protein A affinity resins for initial capture, as well as ion exchange and hydrophobic interaction media for intermediate purification and polishing to remove aggregates and host cell proteins.

For chemical synthesis and recombinant peptides, we provide a complete solution from solid-phase synthesis carriers to separation and purification resins. By leveraging the hydrophobicity differences of reverse-phase silica and polymer resins, efficient separation of peptide products from structurally similar impurities is achieved.

For the separation and purification of mRNA, plasmid DNA, and oligonucleotides. We provide Oligo(dT20) affinity resins for the targeted capture of mRNA, as well as high-resolution ion-exchange and size exclusion chromatography resins suitable for various nucleic acid molecules.

For peptides, oligonucleotides, and complex chemical drugs, we provide end-to-end solutions from solid-phase synthesis carriers to high-resolution chromatography resins, precisely overcoming the bottleneck of separating closely related impurities.

For the separation and purification of recombinant human insulin and its analogs. By combining ion-exchange (for early concentration) with reverse-phase silica chromatography resins (for polishing), it achieves efficient separation of closely related structural isomers such as deamidated variants.

For fermentation-derived and semi-synthetic antibiotics, we provide wide pH-tolerant polymer reverse-phase resins and silica chromatography resins, supporting high-throughput material processing and achieving effective enrichment of active pharmaceutical ingredients (APIs) and separation of fermentation by-products.